Protopic and Kidney duplex - a phase IV clinical study of FDA data
Summary:
We study 5,662 people who take Protopic (tacrolimus) or have Kidney duplex. No report of Kidney duplex is found in people who take Protopic.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Protopic?
Protopic has active ingredients of tacrolimus. It is often used in eczema. eHealthMe is studying from 5,403 Protopic users. Check the latest studies of Protopic.
What is Kidney Duplex?
Kidney duplex (a kidney is split into two separate collecting systems or units) is found to be associated with 19 drugs and 60 conditions by eHealthMe. Check the latest studies of Kidney duplex.
No report is found.
Do you take Protopic and have Kidney duplex?
- Check whether Kidney duplex is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Protopic:
- Protopic (5,403 reports)
Kidney duplex treatments and more:
- Kidney duplex (259 reports)
How severe was Kidney duplex and when was it recovered:
Expand to all the drugs that have ingredients of tacrolimus:
Browse all side effects of Protopic:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Kidney duplex:
Browse all the conditions that are associated with Kidney duplex:
How the study uses the data?
The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Protopic) and Protopic (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Tretinoin and Fludarabine Phosphate - now
- Could Rabeprazole cause Energy Increased? - 7 seconds ago
- Nifedipine and High Blood Pressure for Men aged 60+ - 7 seconds ago
- Nifedipine and Htn for Men aged 60+ - 7 seconds ago
- Nifedipine and Hypertension for Men aged 60+ - 8 seconds ago
- Nifedipine and Hbp for Men aged 60+ - 8 seconds ago
- Cushing'S Syndrome and drugs of ingredients of magnesium - 8 seconds ago
- Nifedipine and Blood Pressure - High for Men aged 60+ - 8 seconds ago
- Prednisolone and Adenovirus Infection for Men aged 30-39 - 9 seconds ago
- Nifedipine and Blood Pressure Increased for Men aged 60+ - 9 seconds ago